Iterum Therapeutics plc (ITRMF) Capital expenditures 2017–2024
Iterum Therapeutics plc (ITRMF) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$2,000FY2024 · since FY2017: $812,000 → $2,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $2,000 | -84.6% |
| FY2023 | $13,000 | -79.0% |
| FY2022 | $62,000 | +1.6% |
| FY2021 | $61,000 | +454.5% |
| FY2020 | $11,000 | -54.2% |
| FY2019 | $24,000 | -73.3% |
| FY2018 | $90,000 | -88.9% |
| FY2017 | $812,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice